Description
This fibrinogen binding peptide has a sequence of EHIPA; it mimic the fibrinogen binding domain of GP IIb/IIIa, preventing fibrinogen-platelet binding; it may exhibit antithrombotic activity.
| Product Unit Size | Cost | Quantity | Stock |
|---|
This fibrinogen binding peptide has a sequence of EHIPA; it mimic the fibrinogen binding domain of GP IIb/IIIa, preventing fibrinogen-platelet binding; it may exhibit antithrombotic activity.
| Purity | ≥98% |
|---|---|
| Formula | C25H39H7O8 |
| Formula Wt. | 565.63 |
| Synonym | EHIPA. |
| Solubility | Soluble in water (2 mg/mL). |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Gartner TK, Loudon R, Taylor DB. The peptides APLHK, EHIPA and GAPL are hydropathically equivalent peptide mimics of a fibrinogen binding domain of glycoprotein IIb/IIIa. Biochem Biophys Res Commun. 1991 Nov 14;180(3):1446-52. PMID: 1953789.
Synthesis impurity
Statin; HMG-CoA reductase inhibitor.
Selective inhibitor of cytochrome P450 1B1 (CYP...
Dihydropyridine, FIASMA; L-type Ca2+ channel bl...
BHA derivative.
Polyphenolic compound present in black tea.
Recombinant HIV-1 glycoprotein antigen fragment...
Cyclic peptide; calcineurin inhibitor.
Anthracenedione, DNA intercalator; Pim-1 inhibi...
Fermentation impurity
GHS-R1a agonist, γ-secretase inhibitor.
Recombinant HIV glycoprotein antigen fragment.<...
Neuroprotective flavonoid
Benzimidazole; microtubule polymerization inhib...
Natriuretic, vasodilatory peptide; B1/2 agonist...
CDK4/6 inhibitor.
Thrombin substrate used to measure thrombin act...
Triazine, melamine derivative, insect growth re...
(S) isomer of omeprazole; H+/K+ ATPase and MAO-...